Cystic fibrosis transmembrane conductance regulator gene mutations in infertile males with congenital bilateral absence of the vas deferens

Tohoku Journal of Experimental Medicine

Volumn 207, Issue 4, 2005, Pages 279-285

  Uzun, Semire ^c   Gökçe, Sina ^a   Wagner, Klaus ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

CBAVD; CF; CFTR gene mutations; Cystic fibrosis; Male infertility

Indexed keywords

CHLORIDE CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; AGENESIS; ALLELE; ARTICLE; AUSTRIA; AZOOSPERMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; EXON; GEL ELECTROPHORESIS; GENE DELETION; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC CODE; GENETIC SCREENING; GENETIC VARIABILITY; HETERODUPLEX ANALYSIS; HUMAN; INTRON; MALE; MALE GENITAL SYSTEM DISEASE; MALE INFERTILITY; MISSENSE MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; VAS DEFERENS;

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EXONS; HUMANS; INFERTILITY, MALE; INTRONS; MALE; MUTATION; UROGENITAL ABNORMALITIES; VAS DEFERENS;

EID: 29144504168     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.207.279     Document Type: Article

References (29)

1. Aittomaki, K., Wennerholm, U.B., Bergh, C., Selbing, A., Hasekamp, J. & Nygren, K.G. (2004) Safety issues in assisted reproduction technology: Should ICSI patients have genetic testing before treatment? A practical proposition to help patient information. Hum. Reprod., 19, 472-476.
2. Anguiano, A., Oates, R.D., Amos, J.A., Dean, M., Gerrard, B., Stewart, C., Maher, T.A., White, M.B. & Milunsk, A. (1992) Congenital bilateral absence of the vas deferens: A pimarly genital form of cystic fibrosis. JAMA, 267, 1794-1797.
3. Augarten, A., Yahav, Y., Kerem, B.S., Halle, D., Laufer, J., Szeiberg, A., Dor, J., Mashiach, S., Gazit, A.E. & Madgar, I. (1994) Congenital bilateral absence of vas deferens in the absence of cystic fibrosis. Lancet, 344, 1473-1474.
4. Boucher, R.C. (2002) An overview of pathogenesis of cystic fibrosis lung disease. Adv. Drug Deliv. Rev., 54, 1359-1371.
5. Casals, T., Bassas, L., Ruiz-Romeo, J., Chillon, M., Gimenez, J., Ramos, M.D., Tapia, G., Narvaez, H., Nunes, V. & Estivill, X. (1995) Extensive analysis of 40 Infertile patients with congenital absence of the vas deferens: In 50% of cases only one CFTR allele could be detected. Hum. Genet., 95, 205-211.
6. Danziger, K.L., Black, D.L., Keiles, S.B., Kammesheidt, A. & Turek P.J. (2004) Improved detection of cystic fibrosis mutations in infertility patients with DNA sequence analysis. Hum. Reprod., 19, 540-546.
7. Dean, M., White, B.M., Amos, J., Gerrard, B., Stewart, C., khaw, K.T. & Leppert, M. (1990) Multiple mutaions in highly conserved residues are found in mildly affected cystic fibrosis patients. Cell, 61, 863-870.
8. Dohle, G.R., Halley, D.J.J., Van Hemel, J.O., van den Ouweland, A.M.W., Pieters, M.H.E.C., Weber, R.F.A. & Govaerts, L.C.P. (2002) Genetic risk factors in infertile men with severe oligozoospermia and azoospermia. Hum. Reprod., 17, 13-16.
9. Fanen, P., Ghanem, N., Vidaud, M., Besmond, C., Martin, J., Costes, B., Plassa, F. & Goossens, M. (1992) Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis transmembrane conductance regulator (CFTR) coding regions and splice site junctions. Genomics, 13, 770-776.
10. Gervais, R., Dumur, V., Rigot, J.M., Lafitte, J.J. & Roussel, P. (1993) High frequency of the R117H cystic fibrosis mutation in patients with congenital absence of vas deferens. N. Engl. J. Med., 328, 446-447.
11. Giovanni, R. & Devoto, M. (1990) Population analysis of the major mutation in cystic fibrosis. Hum. Genet., 85, 391-445.
12. Greil, I. (1995) Mutationsanalyse im Gen für die Cystische Fibrose. Dissertation. Naturwissenschaftlischen Fakultaet, Universitaet Salzburg, Salzburg Austria.
13. Kerem, E., Corey, M., Kerem, B.-S., Rommens, J., Markiewicz, D., Levison, H., Tsui, L.C. & Durie, P. (1990) The correlation between genotype and phenotype in cystic fibrosis analysis of the most common mutation (ΔF508). N. Engl. J. Med., 323, 1517-1522.
14. Larriba, S., Bassas, L., Egozcue, S., Gimenez, J., Ramos M. D., Briceno, O., Estivill, X. & Casals, T. (2001) Adenosine triphosphate-binding cassette superfamily transporter gene expression in severe male infertility. Biol. Reprod., 65, 394-400.
15. Macek, M., Jr., Mercier, B., Mackova, A., Miller, P.W., Hamosh, A., Ferec, C. & Cutting, G.R. (1997) Sensitivity of the denaturing gradient gel electrophoresis technique in detection of known mutations in the CFTR gene. Hum. Mutat., 9, 136-147.
16. Maniatis, T., Fritsch, E.F. & Sambrook, J. (1982) Molecular cloning: In: A Laboratory Manual, 1st ed., edited by Cold Spring Harbor Laboratory Press, New York, USA.
17. Mercier, B., Verlingue, C., Lissens, W., Silber, S.J., Novelli, G., Bonduelle, M., Audrezet, M.P. & Ferec, C. (1995) Is congenital bilateral absence of the vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients. Am. J. Hum. Genet., 56, 272-277.
18. Middendorf, R.L., Bruce, R.C., Eckles, R.D., Grone, D.L., Roemer, S.C., Sloniker, G.D., Steffens, D.L., Sutter, S.L., Brumbaugh, J.A. & Patonay, G. (1992) Continuous, on-line DNA sequencing using a versatile infrared laser scanner/electrophoresis apparatus. Electrophoresis, 13, 487-494.
19. Myers, R.M., Sheffield, V.C. & Cox, D.R. (1988) Detection of single base changes in DNA: Ribonuclease cleavage and denaturing gradient gel electrophoresis. In: Genomic Analysis, A Practical Aproach, edited by K. Davis, IRL Press, Oxford, pp. 95-139.
20. Oates, R.D. & Amos, J.A. (1993) Congenital bilateral absence of the vas deferens and cystic fibrosis: A genetic commonality. World J. Urol., 11, 82-88.
21. Pignatti, P.F. (1994) Cystic fibrosis. In: From Genotype to Phenotype, edited by S. Humpries & S. Malcom, Bios Scientific, Oxford, pp. 19-48.
22. Powell, K. & Zeitlin, P.L. (2002) Therapeutic approaches to repair defects in ΔF508 CFTR folding and cellular targeting. Adv. Drug Deliv. Rev., 54, 1395-1408.
23. Rave-Harel, N., Madgar, I., Goshen, R., Nissim-Rafinia, M., Ziadni, A., Rahat, A., Chiba, O., Kalman, Y.M., Brautbar, C., Levinson, D., Augarten, A., Kerem, E. & Kerem B. (1995) CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens. Am. J. Hum. Genet., 56, 1359-1366.
24. Rommens, J., Kerem, B.S., Gree, W., Chang, P., Tsui, L.C. & Ray, P. (1990) Rapid nonradioactive detection of the major CF mutation. Am. J. Hum. Genet., 6, 395-396.
25. Saiki, R., Gyllensten, U.B. & Erlich, H.E. (1988) The polymerase chain reaction. In: Genomic Analysis, A Practical Aproach, edited by K. Davis, IRL Press, Oxford, pp. 141-152.
26. Uhlen, M. (1989) Magnetic separation of DNA. Nature, 340, 733-734.
27. Wagner, K., Zach, M. & Rosenkranz, W. (1992) Frequency of ΔF508 and haplotype association in Austrian cystic fibrosis families. Hum. Genet., 89, 437-438.
28. Wang, Z., Milunsky, J., Yamin, M., Maher, T., Oates, R. & Milunsky, A. (2002) Analysis by mass spectrometry of 100 cystic fibrisis gene mutations in 92 patients with congenital bilateral absence of the vas deferens. Hum. Reprod., 17, 2066-2072.
29. Zielenski, J., Rozmahel, R., Bozon, D., Kerem, B.S., Grzelczack, Z., Riordian, J.R., Rommens, J. & Tsui, L.C. (1991) Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics, 10, 214-228.